| pubmed-article:15170988 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15170988 | lifeskim:mentions | umls-concept:C0001554 | lld:lifeskim |
| pubmed-article:15170988 | lifeskim:mentions | umls-concept:C0278502 | lld:lifeskim |
| pubmed-article:15170988 | lifeskim:mentions | umls-concept:C0442034 | lld:lifeskim |
| pubmed-article:15170988 | lifeskim:mentions | umls-concept:C0332174 | lld:lifeskim |
| pubmed-article:15170988 | lifeskim:mentions | umls-concept:C0144576 | lld:lifeskim |
| pubmed-article:15170988 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
| pubmed-article:15170988 | lifeskim:mentions | umls-concept:C0205221 | lld:lifeskim |
| pubmed-article:15170988 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:15170988 | pubmed:dateCreated | 2004-6-2 | lld:pubmed |
| pubmed-article:15170988 | pubmed:abstractText | We report 3 gastric cancer patients with peritoneal dissemination who failed to take TS-1 due to adverse effects and who were successfully treated with weekly paclitaxel administered intravenously. The patients were 2 men and 1 woman from 73 to 82 years in age. The histological types of gastric cancer were undifferentiated adenocarcinoma in all cases. Intravenous infusion of TXL (62-80 mg/m2) after short premedication was continued for 3 weeks followed by 1 week rest. Clinical symptoms, including ascites and intestinal obstruction, improved only after administration of 1 cycle in all patients. Except for 1 event with grade 3 neutropenia, no major adverse reactions were observed. Weekly administration of paclitaxel may be a promising chemotherapy for controlling peritoneal metastasis and improving the quality of life of patients with advanced or recurrent gastric cancer. | lld:pubmed |
| pubmed-article:15170988 | pubmed:language | jpn | lld:pubmed |
| pubmed-article:15170988 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15170988 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15170988 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15170988 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15170988 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15170988 | pubmed:month | May | lld:pubmed |
| pubmed-article:15170988 | pubmed:issn | 0385-0684 | lld:pubmed |
| pubmed-article:15170988 | pubmed:author | pubmed-author:HataToshiyuki... | lld:pubmed |
| pubmed-article:15170988 | pubmed:author | pubmed-author:TokukaAtsuoA | lld:pubmed |
| pubmed-article:15170988 | pubmed:author | pubmed-author:YamadaTakakoT | lld:pubmed |
| pubmed-article:15170988 | pubmed:author | pubmed-author:SugimotoShini... | lld:pubmed |
| pubmed-article:15170988 | pubmed:author | pubmed-author:NakamuraKenic... | lld:pubmed |
| pubmed-article:15170988 | pubmed:author | pubmed-author:KanazawaAkiyo... | lld:pubmed |
| pubmed-article:15170988 | pubmed:author | pubmed-author:OzakiNobuhiro... | lld:pubmed |
| pubmed-article:15170988 | pubmed:author | pubmed-author:HikinoHajimeH | lld:pubmed |
| pubmed-article:15170988 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15170988 | pubmed:volume | 31 | lld:pubmed |
| pubmed-article:15170988 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15170988 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15170988 | pubmed:pagination | 759-61 | lld:pubmed |
| pubmed-article:15170988 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:15170988 | pubmed:meshHeading | pubmed-meshheading:15170988... | lld:pubmed |
| pubmed-article:15170988 | pubmed:meshHeading | pubmed-meshheading:15170988... | lld:pubmed |
| pubmed-article:15170988 | pubmed:meshHeading | pubmed-meshheading:15170988... | lld:pubmed |
| pubmed-article:15170988 | pubmed:meshHeading | pubmed-meshheading:15170988... | lld:pubmed |
| pubmed-article:15170988 | pubmed:meshHeading | pubmed-meshheading:15170988... | lld:pubmed |
| pubmed-article:15170988 | pubmed:meshHeading | pubmed-meshheading:15170988... | lld:pubmed |
| pubmed-article:15170988 | pubmed:meshHeading | pubmed-meshheading:15170988... | lld:pubmed |
| pubmed-article:15170988 | pubmed:meshHeading | pubmed-meshheading:15170988... | lld:pubmed |
| pubmed-article:15170988 | pubmed:meshHeading | pubmed-meshheading:15170988... | lld:pubmed |
| pubmed-article:15170988 | pubmed:meshHeading | pubmed-meshheading:15170988... | lld:pubmed |
| pubmed-article:15170988 | pubmed:meshHeading | pubmed-meshheading:15170988... | lld:pubmed |
| pubmed-article:15170988 | pubmed:meshHeading | pubmed-meshheading:15170988... | lld:pubmed |
| pubmed-article:15170988 | pubmed:year | 2004 | lld:pubmed |
| pubmed-article:15170988 | pubmed:articleTitle | [Efficacy of weekly administration of paclitaxel for advanced or recurrent gastric cancer with peritoneal dissemination]. | lld:pubmed |
| pubmed-article:15170988 | pubmed:affiliation | Dept. of Surgery, Shimane Prefectural Central Hospital. | lld:pubmed |
| pubmed-article:15170988 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15170988 | pubmed:publicationType | English Abstract | lld:pubmed |
| pubmed-article:15170988 | pubmed:publicationType | Case Reports | lld:pubmed |
